Leigh Garven Turner

Title(s)Professor, Health, Society and Behavior
SchoolUC Irvine Joe C. Wen School of Population & Public Health
Address856 Health Sciences Quad
University of California, Irvine
Irvine CA 92697-3957
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. US businesses engaged in direct-to-consumer marketing of perinatal stem cell interventions following the Food and Drug Administration's enforcement discretion era. Cytotherapy. 2024 04; 26(4):393-403. Turner L, Wang JC, Martinez JR, Najjar S, Rajapaksha Arachchilage T, Sahrai V. PMID: 38340106.
      View in: PubMed   Mentions: 1     Fields:    Translation:Cells
    2. Businesses marketing purported stem cell treatments and exosome therapies for COVID-19: An analysis of direct-to-consumer online advertising claims. Stem Cell Reports. 2023 11 14; 18(11):2010-2015. Turner L, Martinez JR, Najjar S, Rajapaksha Arachchilage T, Wang JC. PMID: 37890484; PMCID: PMC10679647.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    3. Regulatory claims made by US businesses engaged in direct-to-consumer marketing of purported stem cell treatments and exosome therapies. Regen Med. 2023 11; 18(11):857-868. Turner L, Martinez JR, Najjar S, Arachchilage TR, Sahrai V, Wang JC. PMID: 37867326.
      View in: PubMed   Mentions:    Fields:    Translation:Cells
    4. Safety and efficacy claims made by US businesses marketing purported stem cell treatments and exosome therapies. Regen Med. 2023 10; 18(10):781-793. Turner L, Martinez JR, Najjar S, Arachchilage TR, Sahrai V, Wang JC. PMID: 37795701.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    5. The American stem cell sell in 2021: U.S. businesses selling unlicensed and unproven stem cell interventions. Cell Stem Cell. 2021 11 04; 28(11):1891-1895. Turner L. PMID: 34739831.
      View in: PubMed   Mentions: 13     Fields:    
    6. Ethical issues and public communication in the development of cell-based treatments for COVID-19: Lessons from the pandemic. Stem Cell Reports. 2021 11 09; 16(11):2567-2576. Turner L, Munsie M, Levine AD, Ikonomou L. PMID: 34653406; PMCID: PMC8516140.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCellsPHPublic Health
    7. Hope, hype, cures, and persons with cerebral palsy. Dev Med Child Neurol. 2022 01; 64(1):8. Turner L. PMID: 34536300.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    8. The FDA and the US direct-to-consumer marketplace for stem cell interventions: a temporal analysis. Regen Med. 2018 Jan; 13(1):19-27. Knoepfler PS, Turner LG. PMID: 29327974.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    9. US clinics marketing unproven and unlicensed adipose-derived autologous stem cell interventions. Regen Med. 2015 May; 10(4):397-402. Turner LG. PMID: 26022761.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    10. Federal Regulatory Oversight of US Clinics Marketing Adipose-Derived Autologous Stem Cell Interventions: Insights From 3 New FDA Draft Guidance Documents. Mayo Clin Proc. 2015 May; 90(5):567-71. Turner LG. PMID: 25939934.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    11. Quality in health care and globalization of health services: accreditation and regulatory oversight of medical tourism companies. Int J Qual Health Care. 2011 Feb; 23(1):1-7. Turner LG. PMID: 21148210.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    12. The coming backlash against "medical tourism". Plast Reconstr Surg. 2010 Dec; 126(6):326e-327e. Turner LG. PMID: 21124118.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    Leigh's Networks
    Concepts (44)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (1)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCI Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-9-g3adcefa5 on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California